| 摘要 |
<p>Compounds of the invention are useful in inhibiting thrombin and treating blood coagulation and cardiovascular disorders and have the following structure: where R1 is hydrogen, or C¿1-4? alkyl, (CH2)0-1CN, C(O)R?14, (CH¿2)0-1CO2R14, CF3, OR14, halogen, SR?14, S(O)R14¿, S(O)¿2?R?14, NR14R15¿.</p> |
